Expanded Aerosol Capacity American Spraytech recently expanded its production footprint with a new aerosol facility near its headquarters in Branchburg, NJ. This suggests increased capacity for large-volume, fast-turnaround contracts and potential for onboarding new cosmetics and personal care brands seeking scalable manufacturing and regional diversification.

FDA EPA cGMP Compliance The company operates a cGMP, ISO 13485? (note: ISO 13:485 seems a misprint) compliant facility registered with FDA and EPA, signaling strong regulatory readiness and lower compliance risk for clients in cosmetics, personal care, and OTC drug spaces. This can be a differentiator when pitching to brands prioritizing quality and regulatory alignment.

Diverse Client Base With clients ranging from boutique salons to Fortune 500 consumer goods companies, American Spraytech demonstrates versatility and credibility across brand tiers. This presents a sales opportunity to target mid-market brands seeking premium contract manufacturing with scalable capabilities and established QA processes.

End-to-End Capabilities As a turnkey innovator and contract manufacturer of aerosol and continuous spray products, the company can offer formulation assistance, packaging, and manufacturing under one roof. This integrated service model is attractive to brands aiming to accelerate time-to-market and reduce vendor fragmentation.

Industry Alignment and Growth Revenue in the $100M–$250M range and active investment in assets indicate a growth trajectory and financial stability. This positions American Spraytech as a reliable partner for long-term collaborations, co-development initiatives, or multi-year manufacturing agreements with growth-oriented brands in cosmetics, personal care, and OTC segments.